Welcome
About Victoza®
Executive Bios
Backgrounders
Press Releases
Image Gallery
Featured Video
Annual Report
Subscription Service
Media Contacts
Victoza® (liraglutide [rDNA origin] injection) receives FDA approval for type 2 diabetes.
Victoza® is the first once-daily human glucagon-like peptide-1 (GLP-1) analog developed for the treatment of type 2 diabetes.
Victoza® is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes.
Our Media Relations team is ready to help you get all the information you need about Novo Nordisk.
Actors, Olympia Dukakis and Louis Zorich, partner with Novo Nordisk, to launch Ask.Screen.Know., a campaign to increase awareness and utilization of the Medicare diabetes screening benefit.